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ABSTRACT
Objective: To explore the effect and molecular mechanism of SPHKl in the invasion and
metastasis process of non-small-ceiliung cancer cells (A549). Methods: Recombinant retrovirus
was used to mediate the production of A549/vector, A549/SPHKl, A549/scramble, and A549/
SPHKl/RNAi that stably expressed or silenced SPHKl. The invasion and migration capacities of
A549 cells overexpressing or silencing SPHKl were determined using Transwell invasion assay
and scratch wound repair experiment. The protein and mRNA expression levels of E-cadherin,
fibronectin, vimentin in A549/vector, A549/SPHKl, A549/scramble, A549/SPHKl/RNAi were
detected with Western blot (WB) and quantitative PCR (QPCR) methods, respectively. Results:
Transwell invasion assay and scratch wound repair experiments showed that over-expression of
SPHKl obviously enhanced the invasion and migration capacities of A549 cells. WB and QPCR
detection results showed that, the expression of E-cadherin (a molecular marker of epithelial
cells) and fibronectin, vimentin (molecular markers of mesenchymal cells) in A549 cells was
upregulated after overexpression of SPHKl; while SPHKl silencing significantly reduced the
invasion and metastasis capacities of A549cells, upregulated the expression of molecular marker
of epithelial cells, and downregulated the expression of molecular marker of mesenchymal cells.
Conclusions: SPHKl promotes epithelial mesenchymal transition of non-small-celliung cancer
cells and affects the invasion and metastasis capacities of these cells.
1. Introduction
Tumor metastasis is a multi-stage, multi-step process
involving a variety of genes, it can be summarized as
follows: in situ tumor invasion into the basement membrane
and stroma, crossing through the vascular wall and entering
peripheral circulation, then forming thrombus in blood
vessels and adhering to vascular endothelial cells, breaking
through vascular walls and affecting the stroma in secondary
tissue or organ, ultimately forming secondary tumorslt.zl.
Lung cancer is the first malignant cause of death, it's
estimated that the annual incidence rate is nearly 1.23
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million. The existing therapeutic strategies for non-
small cell lung cancer include surgery, radiotherapy,
chemotherapy and physical therapy. The survival rate
of non-small-cell lung cancer patients is less than 1%.
Radiotherapy and chemotherapy were not completely
effective for treating non-smaIl-cell lung cancer[3-91.
Therefore it is crucial to find molecular markers for
predicting the metastasis and prognosis of lung cancer.
As an oncogene, SPHKl exerts important biological
functions and is highly expressed in a variety of malignant
tumors, it also assists in the regulation of tumor growth,
invasion, metastasis and apoptosis[1O- 121. Preliminary
studies of our research group found that SPHKl is highly
expressed in lung cancer cells and tissues. Although SPHKl
contributes to regulate cell proliferation and growth, the
role of SPHKl in the invasion, metastasis, and epithelial
mesenchymal transition (EMT) of lung cancer cells is
scarcely reported, and the regulatory mechanism has not
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Primer sequences were shown as follows: 
Gene Forward primer Reverse primer
E-cadherin 5’CTGCTGCAGGTCTCCTCTTG 3’ 5’TGTCGACCGGTGCAATCTTC 3’
Fibronectin 5’GACCACATCGAGCGGATCTG 3’ 5’GTCTCTTGGCAGCTGACTCC 3’
Vimentin 5’AAGGCGAGGAGAGCAGGATT 3’ 5’GGTCATCGTGATGCTGAGAAG 3’
毬-Actin 5’TGGCACCCAGCACAATGAA-3’ 5’CTAAGTCATAGTCCGCCTAGAAGCA-3’
i .! i l -
been fully elucidated. Therefore, this study aims to explore
the underlying mechanism of SPHK1 on the invasion and
metastasis of virus-mediated lung cancer cell line A549. The
effect of SPHK1 on the SPHK1-overexpressing and SPHK1-
silencing lung cancer cells was investigated, which provides
evidence for studying the pathogenesis of lung cancer.
2. Materials and methods
2.1. Cells and plasmids
HBE bronchial epithelial cells were purchased from
the Cell Bank of Cancer Institute of Chinese Academy of
Medical Sciences. A549, 95C and 95D cells were provided
from ATCC Cell Bank. Retroviral packaging cell 293FT
and pMSCV-puro-SPHK1, pSUPER-puro-SPHK1 and the
corresponding viral packaging system were presented as a
gift by Guangzhou Boke Cancer Institute.
2.2. Reagents
Fetal bovine serum, RPMI-1640 medium, Transwell
culture plate (GIBCO Company); Matrigel (BD Biosciences);
Puromycin (Invitrogen); E-cadherin, fibronectin, vimentin
antibody, goat anti-rabbit secondary antibody (Abcam);
real-time quantitative PCR (QPCR) kit (Guangzhou Fulen
Gene) were all used in this study. Other reagents and
supplies were purchased from Guangzhou Laura Biotech Ltd.
2.3. Establishment ofstable cell lines A549
The virus was packaged with calcium phosphate
transfection method, then the retroviral packaging plasmid
PIK and retroviral expression plasmids (pMSCV-puro-
SPHK1, pMSCV-Vector, pSUPER-puro-SPHK1, pSUPER-
puro-vector) were transfected into 293FT cells for 5 hours.
The culture medium was replenished 5 hours later. The virus
solution was collected 24 hours later, filtered using 0.45 t-t m
filter, and stored at -80 ·C.
The non-transfected A549 cells were conventionally
cultured. When the cells reached a 70% confluence,
l
l :
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recombinant virus solution and polybrene (8 t-t g/ml.) were
added to transfect the cells for 48 hours. The transfected
cells were then digested and cultured in the medium
containing 0.5 t-t glmL puromycin (Sigma). Cells at passage 5
were harvested and total RNAwas extracted.
2.4. Cellfunction assays
2.4.1. Scratch wound repair experiment
Cells in good growth state were collected and digested,
then seeded in a 6-well culture plate at the density of 5X105
cells, in 37·C incubator with 5%CO2• After the cultured cells
began to adhere, the original culture medium was removed,
cells were rinsed with PBS and starved in serum-free 1640
medium for 24 hours. A scratch wound was made on the
monolayer cells using 100 t-t L sterile pipette, and the cells
were cultured in serum-free medium after the exutive cells
were removed with PBS washing. The repairing process of
scratch wound was observed under an inverted microscope.
The cells were photographed at 0 hour and 24 hours to
record and compare repair speed and manner in different
cells.
2.4.2. Transwell invasion assay
Cells at logarithmic phase were digested. Cell suspension
was seeded in the Matrigel-coated Transwell chamber,
in which the underlayer was supplemented with
RPMI1640 culture containing 10% fetal bovine serum as
chemoattractant solution. After the cells were cultured for 24
hours, the chamber was removed and Matrigel was discarded
with a cotton swab. Cultured cells were fixed in formalin and
stained with hematoxylin. The number of cells penetrating
the membrane was calculated under the microscope.
2.5. Expression of E-cadherin, fibronectin, vimentin in
transfected cells detected by QPCR
Cells at logarithmic phase were collected and digested.
Total RNA was isolated from whole cells using Trizol. RNA
concentration was measured with UVspectrophotometer and
preserved at -20 "C for further use. The housekeeping gene
~ -Actin was served as the reference. The expression levels
'TGTC '
' '
' '
'CT AGCA- '
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of E-cadherin, fibronectin, vimentin in different cell lines
were determined.
with control strain A549/scramble. Experimental results
indicated that, SPHKl-overexpression and SPHKl-silencing
cell lines were successfully established (Figure 2).
2.6. Expression ofE-cadherin,jibronectin, vimentin in stable
cells detected by Western blot (WB)
Figure 1. SPHKlprotein andmRNA expression levels.
A, B: SPHKl protein and mRNA expression levels in para-
carcinomatous tissue by western blot analysis; C, D: SPHKl protein
and mRNA expression levels in lung cancer cell lines by QPCR
detection.
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Cells at logarithmic growth phase were lysated and protein
concentration was detected using the BCA method. A total
of 20 fJ. g total proteins were electrophoresized in 9% SDS-
PAGE gel at 70 V for 4 hours, then transferred to another
film and incubated with E-cadherin, fibronectin, vimentin
antibodies. Subsequently cells were developed with ECL, to
analyze the expression of target proteins.
2.7. Statistical analysis
Data were statistically analyzed using SPSS 18.0 software
for windows (IBM). Measurement data were expressed as
mean±SD. The difference among samples was compared
with one-way analysis of variance. A two-tailed p < 0.05
was considered statistically significantly different.
I
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3. Results
3.3. Invasion and migration of SPHKl-overexpression and
SPHKl-silencing cell lines
Figure 2. Identification ofstablecelllines.
A:Western blotdetection ofSPHKlprotein expression in A549 cells;
B: QPCR detection ofSPHKlmRNA expression in A549 cells.
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The results showed that, SPHKl mRNA and protein
expression in lung cancer tissue was significantly higher
than that in para-carcinomatous tissue (Figure lB, Figure
l D), In addition, SPHKl protein and mRNA expression in
lung cancer cell lines and normal lung epithelial cells were
detected with QPCRand western blot analysis, respectively.
The results showed that, SPHKl protein and mRNA
expression in lung cancer cell lines was increased when
compared with normal lung cells (Figure lA, Figure lC).
3.1. SPHKl protein and mRNA expression in lung cancer cell
lines and para-carcinomatous tissue
3.2. SPHKl-overexpression and SPHKl-silencing cell lines
were successfully established
The viruses carrying SPHKl-overexpression and
SPHKl-silencing genes were transfected into A549
cells. The transfected cells were then screened with
0.5 fJ. g/mL puromycin and total RNAwas extracted from the
7-generation cells. QPCR and western blot assay showed
that, SPHKl was expressed less in control strain A549/vector
than in A549/SPHKl, while SPHKl expression in A5491
SPHKl/RNAi was significantly decreased when compared
Transwell assay showed that, more GPC-transduced A5491
SPHKl cells, rather than A549/vector, penetrated through
the basement membrane; the number of A549/SPHKl/RNAi
penetrating the basement membrane was significantly lower
than A549/scramble (Figure 3A). In scratch wound repair
experiments, the scratch wound in control strain A549/vector
was repaired slowly than that in A549/SPHKl; but A5491
SPHKl/RNAi cells migrated slowly than the A549/scramble
(Figure 3B). Our findings suggested that overexpression of
SPHKl could promote cell migration and invasion, and the
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body, the occurrence and metastasis of tumor cells are
extremely complex and cumbersome, involving both
external and internal factors[13,14J. The most crucial event
triggering tumor invasion and metastasis is the alterations
of phenotype molecule and adhesion molecule in epithelial
cells, which is also called EMT. When the tumor metastasis
function is changed, EMT-associated molecules are
changed accordingly, such as increasing the expression of
mesenchymal cells specific proteins (Vimentin, fibronectim,
and decreasing the expression of epithelial cell adhesion
protein (E-cadherin)[15,16]. The down-regulation of adhesion
protein's expression may lead to the loss of intercellular
adhesion, and actually tumor cells are shed and migrate
to distant parts, resulting in tumor metastasis and exerting
a super-strong invasive ability[17-19J. The migration and
invasion capacities of tumor cells educed with functional
changes are regarded as EMT[20J.
Preliminary studies of our research group have found
that, SPHKl was highly expressed in lung cancer cell lines
and para-carcinomatous tissue, and it can regulate cell
metastasis. This evidence indicates that SPHKl expression
may be associated with metastasis. In this study, we
established SPHKl-overexpressing and SPHKl-silencing
lung cancer cell models A549/SPHKl and A549/SPHKIIRNAi
with retrovirus mediated methodlzr-zsl. QPCR and western
blot assay results showed that, lung cancer cells still highly
expressed SPHKl even after 7 passage of culture. Using
these highly expressed cells, we ensured the reproducibility
of experimental results of cell function assays and related
markers. The cell morphology maintained unchanged in
the course of routine culture. In Transwell invasion assay
and scratch wound repair experiments, the migration and
invasion capacities of A549 cells were obviously inhibited
after silencing SPHKl, while obviously enhanced after
overexpressing SPHKl. QPCRand western blot analysis were
used to detect the expression of EMT-related molecules after
over-expressing and silencing SPHKl. The results found
that over-expression of SPHKl obviously down-regulated
the expression of epithelial cell marker E-cadherin in
A549 cells, while significantly upregulated the expression
of mesenchymal cell markers, vimentin and fibronectin.
Silencing SPHKl achieved the reverse effects, increasing
E-cadherin expression, decreasing vimentin and fibronectin
expression in A549 cells. Our findings suggest that SPHKl
can promote the invasion and metastasis of lung cancer cells
A549,and trigger EMT.
In summary, we observed the changes of EMT phenotype
and surface receptor signaling molecules, and found that
SPHKl expression contributed to regulate EMT in A549cells,
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Figure 3. SPHKl regulates the migration and metastasis of A549
cells.
A: Transwell invasion assay; B:scratch wound repairexperiments.
Figure 4. Western blot analysis (A) and QPCR (B) detection of the
expression ofEMT-related molecular markers following SPHKlover-
expression.
Non-smaIl-cell lung cancer occupies 80% of all lung
cancers according to the pathology classificationlzl, therefore
it is critically important to emphasize non-smaIl-cell
lung cancer models. Growing evidence demonstrated that,
the majority of lung cancer patients die of tumor invasion
and metastasis. Human body is an integrated regulatory
4. Discussion
3.4. Effect ofSPHKl ooerexpressioti on the EMT
effect was enhanced along the increasing expression of
SPHKl.
WB and QPCRmethods were used to detect the expression
of EMT-related markers in A549 cells after SPHKl
overexpression and silencing. The results showed that,
overexpression of SPHKl significantly decreased the
expression of E-cadherin (marker of epithelial cells) in
A549 cells, while significantly increased the expression of
vimentin and fibronectin (markers of mesenchymal cells)
(Figure 4). The results suggested that overexpression of
SPHKl obviously promoted the EMT process.
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and affected the invasion and metastasis of tumor cells,
leading to cell functional changes. This study will provide a
theoretical basis for future investigations on non-small-cell
lung cancer mechanism, diagnosis, treatment and prognosis.
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